ecrin-mdr-crcClinical2014Colorectal CancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2630698Japan9ECRIN MDRCompletedfalseTANDEM-IRI-TACE combined with systemic FOLFIRI for colorectal liver metastases after oxaliplatin regimen failure: Phase I dose escalation studyInterventions: TACE will be conducted every 5 weeks. Systemic FOLFIRI will be conducted every 2 weeks. Primary outcome(s): Dose Limiting Toxicity,Recommended Dose Study Design: Single arm Non-randomized2014-09-152630698JPRN-UMIN000015367